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Background: Few epidemiological data on autism spectrum disorders (ASD) exist for Arabic countries. We conducted
the first survey of ASD in Qatar, a population with high consanguinity level. Methods: This cross-sectional survey
was conducted from 2015 to 2018 in Qatar school-age children (N = 176,960) from national and immigrant families.
Children diagnosed with ASD were identified through medical centers and special needs schools. Records were
abstracted and supplemented by parental interviews. Additionally, children attending 93 schools were screened; ASD
case status was confirmed in random samples of screen-positive and screen-negative children. Prevalence was
estimated after taking into account different sampling fractions and participation rates at each survey phase.
Results: One thousand three hundred and ninety-three children already diagnosed with ASD were identified. Among
9,074 school survey participants, 760 screen-negative children and 163 screen-positive children were evaluated; 17
were confirmed to have ASD including five children newly diagnosed. Prevalence was 1.14% (95% CI: 0.89–1.46)
among 6- to 11-year-olds. ASD was reported in full siblings/extended relatives in 5.9% (95% CI: 0.042–0.080)/11.8%
(95% CI: 0.095–0.146) families. First-degree consanguinity in Qatari cases (45%) was comparable to known
population levels. Among 844 ASD cases (mean age: 7.2 years; 81% male), most children experienced language delay
(words: 75.1%; phrase speech: 91.4%), and 19.4% reported developmental regression. At the time of the survey,
persisting deficits in expressive language (19.4%) and peer interactions (14.0%) were reported in conjunction with
behavioral problems (ADHD: 30.2%; anxiety: 11.0%). In multivariate logistic regression, ASD severity was associated
with parental consanguinity, gestational diabetes, delay inwalking,anddevelopmental regression.Conclusions: ASD
prevalence in Qatar is consistent with recent international studies. The methods employed in this study should help
designing comparable surveys in the region. We estimated that 187,000 youths under age 20 have ASD in Gulf
countries. This figure should assist in planning health and educational services for a young, fast-growing population.
Keywords: Arabic; autism spectrumdisorders; epidemiology; screening; prevalence; child; school age; consanguinity;
regression.
Introduction
Autism spectrum disorder (ASD) is characterized by
pervasive impairments in social reciprocity, commu-
nication, stereotyped behaviors, and restricted inter-
ests (APA, 2013). Reviews concluded that best
estimates for ASD prevalence are around 1% (Elsab-
bagh et al., 2012; Meyers, Presmanes Hill, Zucker-
man, & Fombonne, 2018), with some studies yielding
estimates over 2% (Kim et al., 2011; Pelly, Vardy,
Fernandez, Newhook, & Chafe, 2015; Randall et al.,
2016). Four surveys in Arabic countries relied on
unreliable methods (see Table S1). There is no stan-
dardized methodology to conduct ASD surveys, and
variation in reported prevalence reflects, at least in
part, this lack of standardization. ASDprevalence has
increased steadily, but the interpretation of this trend
remains uncertain (Fombonne, 2009). Survey meth-
ods variability, changes in diagnostic concepts and
criteria, diagnostic substitution, improved identifica-
tion, and awareness contributed to it (Hill, Zucker-
man, & Fombonne, 2014). Yet, an increase in ASD
incidence could also account for a portion of the
upward prevalence trend; if so, it could point to
environmental risk factors in ASD etiology operating
with or in addition to well-established genetic factors
(Willsey & State, 2015; Woodbury-Smith & Scherer,
2018). Consequently,monitoring ASDprevalence has
become a public health priority in many countries.
Case ascertainment in earlier studies relied on iden-
tifying children already diagnosed with ASD. Improve-
ment on thismethodology was brought about in the US
Centers for Disease Control and Prevention (CDC)
surveillance program (Yeargin-Allsopp et al., 2003).
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TheCDCmethodology screens the child population age
8;medicaloreducational recordscontainingevidenceof
a social ‘trigger’ are abstracted whether or not an ASD
diagnosis is already reported. An expert panel subse-
quently derives a best estimate diagnosis (Van Naarden
Braun et al., 2007). Limitations to this methodology
include an absence of surveys of children without ser-
vices contacts and of direct diagnostic evaluation (Fom-
bonne, 2018). The addition of a school survey in recent
studies (Fombonne et al., 2016; Kim et al., 2011) has
addressedoneoftheselimitations.However,variabilityin
methods and participation resulted in new challenges;
despite applying appropriate weights to account for
different sampling andparticipation rates at eachsurvey
phase, unchecked assumptions may have biased
upwards prevalence estimates (Fombonne, 2018; Pan-
telis&Kennedy, 2015).
Most surveys have been conducted thus far in
Western countries (Elsabbagh et al., 2012).World pop-
ulations differ for economic wealth, nutritional status,
maternal and child health, and genetic background as
well as rates of consanguinity. Arabic countries have
among the highest rates of consanguineous marriages
(20%–50%;Tadmouri et al., 2009) that increase ratesof
homozygotes for recessive disorders and that may
modulate the population risk of autism. Risk of ASD
has not been studied in relation to population level of
consanguinity.Weconducted thefirstprevalencestudy
of ASD inQatar, a countrywith frequent and increasing
first-cousin marriages. The main objectives were (a) to
assess the prevalence of ASD among school-age chil-
dren; (b) to describe correlates and developmental
characteristics of children with ASD.
Methods
Site
Qatar is one of the Gulf Cooperation Council countries (GCC,
including Saudi Arabia, Bahrain, United Arab Emirates, Oman,
andKuwait), with a population of 2.7million (26%under age 25)
(Ministry of Development Planning & Statistics,
2018a,2018b,2018c). The literacy rate is high (>96%) (UNICEF,
2016). School attendance is mandatory at age 5 and free
(Ministry of Education, 2016). Free healthcare is available for
nationals and residents,mostly delivered by theHamadMedical
Corporation (HMC, n.d.). Consanguineousmarriage is frequent
(>50%) in Qatar and other GCC countries (Bener & Alali, 2006).
Special provisions exist for individuals with disabilities.
Preschoolers are referred to Child Development Center at HMC
(CDC-HMC). ASD is a separate eligibility special education
category, and school-age children are evaluated by the Roaa’
Center for Evaluation and Consultation (RCEC) funded by the
Ministry of Education. After a multidisciplinary evaluation,
RCEC issues individualized education plans shared with the
parents. Students suspected to have ASD are referred to the
CDC-HMC or the Shafallah Center for a comprehensive medical
and diagnostic assessment. The ASD diagnostic teams in both
HMC and Shafallah Center comprise developmental pediatri-
cians, psychologists, general pediatricians, speech patholo-
gists, behavioral analysts, and therapists. All diagnosticians are
trained to the Autism Diagnostic Interview – Revised (ADI-R)
(Rutter, LeCouteur, & Lord, 2003) and the Autism Diagnostic
Observational Schedule (ADOS) (Lord, Rutter, DiLavore, & Risi,
2002). Based on family preference, assessments are conducted
in Arabic or English by bilingual staff, and when needed, in
another language with a translator.
Every public school includes special education staff and a
coordinator office (Alshaban, 2018). Educational support for
students with ASD is free. Reflecting various degrees of
impairment, education for students with special needs ranges
from full to partial integration within mainstream classrooms
to attendance of special education classes or centers.
Sample selection
The target population was 5- to 12-year-old children born
between January 1, 2005, and December 31, 2012, residing in
Qatar (Qatari or expatriates). The total population was divided
into two separate strata. First, through systematic screening of
records at each data source, we identified all children who had
been in contact with health or educational services for devel-
opmental, medical, behavioral, or learning problems and
diagnosed with ASD (Qatar Clinical Centers; QCC). Second,
we undertook a survey of the general population of children
meeting inclusion criteria (Qatar School Survey; QSS).
Case finding methods
Qatar School Survey. Each school has its own database
which includes students’ names, sex, date of birth, andaddress.
Screening phase: The Ministry of Education issued a
letter encouraging each school participation to the survey. The
team contacted 216 primary schools, and 172 were visited. Of
these, 39 schools did not participate, 40 schools expressed an
initial interest but later opted out mostly due to shortage of
supportive staff, and 93 schools (N = 62,011 students) were
finally included. Meetings were organized with staff and
sometimes families to explain the study protocol. A school-
based coordinator established the list of students between the
ages of 5 and 12 years attending grades 1–6. Children aged 5
attending kindergarten were not surveyed. Envelopes contain-
ing the screening instrument, a letter, a brochure about ASD
and the consent letter were sent to parents and one reminder
sent 2 weeks later. Screening questionnaires were scored, and
participants subsequently ascribed to the ‘screen-negative
group’ or ‘screen-positive group’ (see Figure 1) depending on
whether or not their total score was below or above the
previously validated threshold (see below).
Diagnostic confirmation phase: Parents from both
screening groups were contacted by phone at least five times.
In 182 cases, families could not be reached (incorrect/discon-
nected number). A family was considered to be a definite refusal
when parents declined participation or could not be reached.
Screen-negative (screen) group—A brief semistruc-
tured telephone interview (QSS-PTI; see below) was adminis-
tered to rule out ASD in their child; when descriptions were
ambiguous or suggestive of autism-like symptoms, parents
were invited to an in-person evaluation. We randomly selected
and contacted 1,242 participants (15% of the 8,301 screen).
We kept inviting parents up to the point where about 10% of
the screen group could be evaluated. Overall, 760 (61.2%;
9.8% of all screen) completed the QSS-PTI.
Screen-positive (screen+) group—Parentswere invited to
a direct assessment with their child; whenever this was not
possible (distance, scheduling difficulty, parent preference), we
used instead theQSS-PTI.Wekept invitingparentsup to thepoint
where at least 20% of participants could be evaluated. Of 352
families invited, 163 participated (46.3%; 21.1% of the 773
screen+). In112participants (68.7%of the163evaluatedscreen+),
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ASD could be confidently ruled out after QSS-PTI completion. The
remaining 51 families (31.3% of the 163 evaluated screen+)
participated in in-personevaluations; all evaluationsbut onewere
conducted in QBRI research offices (one at school).
Qatar Clinical Centers. QCC sites: Children already
diagnosed with ASD were identified at eight sources (for site
details please see Appendix S1 in Supporting Information).
Data collection: A total of 1,393 unique children were
retained in theQCCsample.During the4 years of the survey,we
located and abstracted medical/educational records for 839
cases. Resource limitations did not allow for data abstraction on
the remaining 554 children.However, on a subsample (N = 110;
19.9%),weconfirmed theaccuracyof theASDdiagnosiswith the
clinical team. Consistent with the 839 abstracted cases, mean
age was 6.8 years (SD = 1.59) and there were 79.4% boys.
Diagnosis had been established via multidisciplinary assess-
mentusingtheADOS(Lordet al.,2002)andastructuredclinical
evaluation in 51 cases (46.4%) and only structured clinical
diagnosis in the remaining 59 (53.6%).
For the 839 cases, we supplemented and updated the record
information with current parental reports. In 108 cases
(12.9%), parents could not be contacted. For the remainder
731 cases, 5 (0.7%) refused to participate (but consented to
record abstraction), and 235 direct interviews and 491 tele-
phone interviews were performed.
Instruments
QSS screening phase: Social Communication
Questionnaire (SCQ). We used the Lifetime version of
the SCQ (Rutter, Bailey, & Lord, 2003) that evaluates partic-
ipants’ developmental history and current behaviors (either
Arabic or English version). It comprises 40 questions with ‘yes’
or ‘no’ responses that can be answered in <10 min. Each item
is scored as 0 or 1, and the sum of 39 item scores yields a total
SCQ score ranging from 0 to 39. In the original validation,
cutoffs of 15 and 22 had been proposed to identify children
with a broad or narrow form of ASD (Berument, Rutter, Lord,
Pickles, & Bailey, 1999). A cutoff of 12 was also proposed to
optimize SCQ performance in population-based samples
(Eaves, Wingert, Ho, & Mickelson, 2006).
In our pilot study (Aldosari et al., 2019), we recruited 412
children [73.8% males; mean age: 8.5 years (SD = 2.6); 206
with ASD, 206 typically developing (TD)]. The mean SCQ total
score was significantly higher in the ASD group (mean differ-
ence: 13.8 points; p < .0001) and showed excellent discrimi-
nation between ASD and TD children (Area Under the
Curve = 0.95; 95% CI: 0.93–0.97). The cutoff of 15 achieved
an optimal tradeoff between sensitivity and specificity and was
subsequently employed to define screened positive or negative
status in the QSS.
QSS diagnostic confirmation phase. To establish
ASD case status, we relied either on a telephone interview or
an in-person diagnostic assessment.
Semistructured telephone interview: The QSS Par-
ental Telephone Interview (QSS-PTI) covered basic socio-
demographic data, and screening questions about current
and/or past presence of communication, social relationships,
atypical behaviors consistent with DSM 5 diagnostic criteria,
disruptive or emotional problems, learning or social
Figure 1 Qatar autism survey flowchart
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difficulties, and other developmental abnormalities. Additional
questions about current peer relationships and teacher con-
cerns about child’s adjustment at school were asked. The
interview lasted 20–30 min. All interviewers were well experi-
enced in conducting clinical interviews with caregivers of
children with ASD. Behavioral descriptions were written down
for later coding. The presence/absence of each other problem
area was rated as present (=1) or absent (=0). A rating of 1
meant that significant symptoms associated with impaired
functioning were evidenced. Children with no teacher and
parent concern, normal peer relationship and no evidence of
autistic symptom were ruled out for ASD. Children with
evidence of such symptoms in combination with impairment
in at least one area of functioning were selected for the next
stage.
In-person diagnostic assessment: These assess-
ments (duration: 2.5 hr) were conducted by at least two of
four members of the research team, all with ASD clinical
experience and trained to the ADI-R (Rutter, LeCouteur et al.,
2003; Rutter, Bailey et al., 2003) and ADOS-2 (Lord et al.,
2002). One staff member interviewed caregivers while another
one evaluated the child through direct observation and the
ADOS-2 (Lord et al., 2002) when needed.
QCC – Abstraction Form (QCC-AF). The QCC-AF was
developed to abstract clinical information deriving from
records and parental interviews. It contains sections on
socio-demographics, medical and developmental history,
comorbid medical, behavioral and genetic conditions, past/
current educational and service use. Country of origin was
coded in four categories: Qatar, other Gulf countries, other
Arabic countries, and other non-Arabic countries. Parental
ages were used as continuous variables and also grouped in 6-
year bands (collapsed in three for some analyses). Parental
education was coded on four levels as follows: Primary school,
Secondary school, College level, and Master degree or higher
(collapsed in three for some analyses). Consanguinity was
considered present for parents who were first-degree or
second-degree cousins; only first-degree consanguinity was
retained for analyses on severity. Recurrence of ASD was
separately coded for siblings (full and half) and for extended
relatives. Low birthweight (BW) was calculated as
BW < 2,500 g. Motor delay was defined as delay in Sitting
(≥8 months) or in Walking (≥18 months). Language delay in
early childhood was defined as Delay in first use of words
(≥24 months) and Delay in phrase speech (≥33 months), sim-
ilar to definitions used in the ADI-R (Rutter, LeCouteur et al.,
2003) that also relies on retrospective parental reporting.
Current level of receptive language was coded in two cate-
gories: Good to Excellent, and Poor to Limited. All other
variables were coded as Present (=1) or Absent (=0). For
gestational maternal disease, obstetric complications, devel-
opmental regression involving loss of language or other skills,
we created summary variables including any event in the
underlying category. Data missing for over 25% of the sample
(e.g. results of baseline medical workup, cognitive testing
scores) are not reported.
We generated a composite severity score (CSS) by combining
information on current functioning. Specifically, a score of 0
for no/lesser impairments and one for highest impairment was
attributed to six items assessing the following: Receptive
language, Expressive language, Reduced peer interactions,
Academic performance difficulties, Requires behavioral support
at school, Any emotional/behavioral problem. Item scores were
summed into a composite ranging from 0 to 6 for each subject.
The CSS sample mean was 1.0 (SD = 1.05; median = 1.0). The
CSS distribution significantly departed from the normal dis-
tribution (Shapiro–Wilk test: p < .0001), and no statistical
transformation could restore normality; thus, the CSS was
dichotomized and analyzed categorically. Two fifths of the
children (38.2%) had a CSS of 0, and 36.1% had a score of 1;
these children were combined into the same low impairment
category. The remaining children (25.7%) had a CSS score of 2
(17.1%), 3 (5.8%), or ≥4 (2.8%) and were combined into a high-
impairment category.
Final case determination
All available data were reviewed by the research team and a
final diagnosis confirmed. Case confirmation was guided by
DSM 5 (APA, 2013) diagnostic criteria for ASD although
uneven levels of information did not allow for reliable scoring
of individual diagnostic criteria. Diagnoses of Pervasive Devel-
opmental Disorder previously made in DSM-IV-TR (APA, 2000)
were verified and converted to DSM 5 (APA, 2013) ASD
diagnoses.
Ethical approval
Ethical approval was obtained from the QBRI and HMC
Institutional Review Boards.
Statistical analyses
Qatar Clinical Centers-AF data were analyzed in SPSS (IBM
Corporation, Armonk, NY), and conventional statistical tests
for categorical (Fisher’s exact test; chi-square) and continu-
ous variables (t tests, Pearson or Spearman correlation
coefficients) were used. Binary and multivariate logistic
regression was used to evaluate predictors of binary vari-
ables. Variables with high (>25%) levels of missing data were
excluded, and no imputation technique was used to adjust
for variable- or item-level missingness. In line with current
recommendations from epidemiologists and biostatisticians
(Perneger, 1998; Rothman, 2014), we did not use Bonfer-
roni’s adjustment for multiple tests. Throughout, a p-value
of .05 was therefore retained as level of statistical
significance.
Prevalence calculations estimated two mutually exclusive
prevalence proportions that were summed to generate a total
population prevalence. The first prevalence figure was for
already-diagnosed cases, and the second prevalence estimate
was for newly diagnosed cases. Because the primary schools
survey focused on grades 1–6 and did not consistently sample
children age 5 (still in Kindergarten) or 12 (already in middle
school), we restricted the study population to 6- to 11-year-
olds for the purpose of prevalence calculations. The prevalence
for already-diagnosed cases was arrived at by dividing the total
number of cases ages 6–11 identified through the QCC
component of the survey (see Figure 1) by the population size
of residents aged 6–11 (N = 133,781) as per the national
census from April 2015 (Ministry of Development Planning &
Statistics, 2015).
The prevalence for newly diagnosed ASD cases reflected the
results of the QSS component of the survey as a weighted
average of the screen-positive and screen-negative groups. To
execute the weighting and to estimate confidence intervals that
reflected the level of uncertainty due to sampling variation, we
simulated the sampling process from a hypothetical popula-
tion based on the observed results in the QSS. The number of
children with negative and positive screening results who
participated in diagnostic status confirmation were simulated
from binomial distributions with parameters n (number of
trials) and p (probability of ‘success’) set to the observed sizes
and participation rates of the screen+ and screen groups.
From the resulting numbers, we simulated newly diagnosed
cases with probability corresponding to the observed results
(number of newly diagnosed cases/number of screen+ or
screen, respectively). Where this number equaled zero, we
added a small correction factor (n = 0.5) to the numerator so
© 2019 The Authors. Journal of Child Psychology and Psychiatry published by John Wiley & Sons Ltd on behalf of Association for
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that the simulations would vary from zero. The prevalence of
new diagnoses in each of the two groups was calculated. To
translate these specific screening-phase results prevalence
estimates into a population estimate, we also simulated the
first phase of the screening process, using the screen+ and
screen proportions as binomial probabilities and the number
of children screened as the number of trials. We applied our
estimated prevalence from the previous step to find the
expected number of cases in each screening group. These
served as the numerator for a final prevalence estimate, with
the number screened as the denominator. We repeated this
simulation 10,000 times. We used the mean prevalence from
this simulation as the point estimate and the 2.5th and 97.5th
percentiles as the bounds of the 95% confidence interval.
Prevalence estimation was performed with Stata software,
version 15 (StataCorp, 2017).
The total population prevalence was obtained by sum-
ming the prevalence proportions estimated for already-
diagnosed (QCC) and newly diagnosed (QSS) cases. To
obtain estimates of precision, we simulated the expected
number of cases from the QCC from a binomial distribution
with the census population as the number of trials. We
used our previously simulated prevalence estimates to
obtain the expected number of newly diagnosed cases in
the entire school-age population (prevalence*population).
We then took the 2.5th and 97.5th percentiles of the
resulting prevalence estimates over 10,000 simulations as
the 95% confidence interval. To obtain age- and gender-
specific estimates, we applied the age and gender distribu-
tions from the QCC to our simulated cases and used
population estimates as denominators. Because there were
too few cases newly identified through the school survey,
age and gender prevalence calculations could not be
reliably adjusted for the specific gender and age distribu-
tion observed among the few new diagnoses within the
QSS; thus, we defaulted to the QCC age and sex distribu-
tion for the QSS prevalence components.
We expected to identify in the QSS children already
diagnosed and ascertained in the QCC. This provided a
unique opportunity to generate a second estimate for the
prevalence of already-diagnosed cases, this time derived from
the school survey. We used the same statistical approach as
that (described above) employed for the newly diagnosed
cases in the QSS. We hypothesized that the two estimates
generated with different methods should converge
reasonably.
Other study features
Please see Appendices S2 and S3.
Results
Qatar School Survey
Screening phase. A total number of 9,074 SCQ
were returned by parents. The mean total SCQ score
was 6.8 (SD = 5.3) (Table 1); 771 children (8.5%)
scored at or above the cutoff. Gender was associated
with screening status (p < .003) with 9.6% of boys
and 7.8% of girls scoring above the SCQ cutoff. Mean
SCQ total scores increased significantly with age in
the entire sample (F = 15.2; p < .001) as well as in
boys and girls separately (p < .001). The proportion
of screen-positive children increased from 6.4%
among 5- to 6-year-olds to 10.8% among 11- to 12-
year-olds (p < .001). The age trend was the same in
girls and boys (Table 1), making it unlikely that the
higher proportion of screen-positive children at older
ages was due to increasing detection of ASD. There-
fore, the reasons for the increase of SCQmean scores
and percentage above cutoff remain uncertain; how-
ever, the SCQ is a lifetime measure and score gains
with age would be expected. SCQ test–retest results
are provided in Appendix S3.
Diagnostic confirmation phase. Of the760screen
children who participated in the second phase, three
children (two males, one female) turned out to have
ASD that had been already diagnosed. We confirmed
thesediagnosesby evaluating in-personone childand
used parent interviews and medical record review for
the other two. These three children had also been
identified by the other case ascertainment approach
and were included in the QCC. In the remaining 757
children (mean age: 9.5 years (SD = 1.8); 46.5%
Table 1 School survey: screening results (N = 9,074)
N
SCQ total score X (SD) Screening statusa N (%)
p-ValuebAll Screen  Screen + Negative Positive
All subjects 9,074 6.8 (5.3) 5.7 (3.7) 19.1 (4.2) 8,303 (91.5) 771 (8.5)
Age 5–6 1,321 6.2 (5.1) 5.2 (3.6) 19.8 (4.8) 1,237 (93.6) 84 (6.4) <.001
Age 7–8 3,399 6.7 (5.3) 5.6 (3.7) 19.5 (4.5) 3,138 (92.3) 261 (7.7)
Age 9–10 2,765 6.9 (5.2) 5.7 (3.7) 18.4 (3.6) 2,511 (90.8) 254 (9.2)
Age 11–12 1,589 7.4 (5.5) 6.0 (3.7) 19.1 (4.3) 1,417 (89.2) 172 (10.8)
All boys 3,716 7.2 (5.5) 5.9 (3.7) 19.4 (4.3) 3,358 (90.4) 358 (9.6)
Age 5–6 532 6.3 (5.1) 5.4 (3.7) 19.8 (4.6) 498 (93.6) 34 (6.4) .01
Age 7–8 1,517 7.2 (5.5) 5.9 (3.7) 19.5 (4.3) 1,378 (90.8) 139 (9.2)
Age 9–10 1,096 7.3 (5.5) 5.9 (3.8) 18.7 (3.7) 975 (89.0) 121 (11.0)
Age 11–12 571 7.9 (5.8) 6.3 (3.7) 20.3 (4.9) 507 (88.8) 64 (11.2)
All girls 4,960 6.6 (5.1) 5.5 (3.6) 18.9 (5.1) 4,572 (92.2) 388 (7.8)
Age 5–6 694 6.1 (5.1) 5.1 (3.5) 20.1 (5.1) 649 (93.5) 45 (6.5) <.001
Age 7–8 1,730 6.3 (5.0) 5.4 (3.6) 19.4 (4.8) 1,617 (93.5) 113 (6.5)
Age 9–10 1,560 6.6 (5.0) 5.6 (3.7) 18.2 (3.5) 1,437 (92.1) 123 (7.9)
Age 11–12 976 7.3 (5.4) 5.9 (3.7) 18.5 (3.9) 869 (89.0) 107 (11.0)
aPositive or negative status is defined by a Social Communication Questionnaire (SCQ) total score either ≥ or < 15 (see text).
bComparisons (chi-square) of the percentages of screen-negative and screen-positive children between the 4 age categories.
© 2019 The Authors. Journal of Child Psychology and Psychiatry published by John Wiley & Sons Ltd on behalf of Association for
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male), one child was assessed in-person and a diag-
nosis of ASD was definitely ruled out. All other 756
children did not present any behavioral or social
characteristic suggestive of ASD. Some children were
reported to have other problems including ADHD
(N = 4; .5%), developmental problems (e.g. language
delay;N = 7; 0.9%), learning difficulties (N = 7; 0.9%),
or behavioral problems (N = 1; .1%).
The screen+ sample [45.4% male; mean age:
8.6 years (SD = 2.1)] had a mean SCQ score of 19.1
(SD = 4.5). Among the 163 participants, 14 were
found to have ASD [13 males, one female; mean age:
8.0 (SD = 2.1); mean SCQ score: 20.8 (SD = 4.3)]; of
these, five cases were newly diagnosed as part of the
survey. All but one child had in-person evaluations.
ASD diagnosis in the other child was confirmed with
parental interview later corroborated by medical
record review. In the remaining 149 children [40.9%
male;meanage: 8.6 (SD = 2.1);meanSCQscore: 19.0
(SD = 4.5)], once ASD had been ruled out, the evalu-
ation suggested the following problems: ADHD (N = 9;
6%), behavioral and emotional problems (N = 10;
6.7%), social and adjustment problems (N = 7; 4.7%)
and specific learning difficulties (N = 3; 2.0%).
In the combined screen+ and screen samples, the
17 children identified as having ASD had signifi-
cantly higher SCQ scores than the reminder sample
(19.2 vs. 6.8; p < .001) and were disproportionately
males (15 males). There was no statistical difference
for mean SCQ scores (20.8 vs. 18.5; NS) or for gender
(P = .51) between the five newly diagnosed and the
12 already-diagnosed children with ASD.
Prevalence estimation
The prevalence of newly diagnosed ASD was 0.32%
(0.09%–0.64%). The numbers of screen+ and screen
childrenparticipating indiagnostic confirmationwere
simulated using a binomial distribution with proba-
bilitiesof760/8301and163/773, respectively,based
on observed participation. We drew newly diagnosed
cases with probabilities 0.5/760 and 5/163 and
calculated the prevalence of new diagnoses in each
screened group. We then simulated the screening
process, drawing from a binomial with probability
8301/9074 and 773/9074 for screen and screen+
results, respectively. Wemultiplied these numbers by
our calculated screening-result-specific prevalences
tofindtheexpectednumberofcases forournumerator
andusedthesumofsimulatedscreen+andscreenas
the denominator for the final prevalence estimation.
The prevalence of already-diagnosed ASD cases
from the QCC was 0.82% (95% CI: 0.77–0.87),
calculated as 1,094 cases/133,781 children ages
6–11 in the 2015 census.
Summing prevalence of already and newly diag-
nosed cases, the total prevalence was estimated at
1.14% (0.89%–1.46%)
We tested the impact of potential misclassification.
In the QCC, 403 cases aged 6–11 could not be
confirmed by the same protocol of full record
abstraction and parent interview. If we posit that
10% of these were not actual ASD cases, the preva-
lence of already-diagnosed ASD would be 0.79%
(0.74%–0.84%). If 20% of the 403 were noncases, the
estimated prevalence of already-diagnosed ASD
would be 0.76% (0.71%–0.81%).
Among all children in the QCC, ages 5–12, we
found 1,398 cases. Using the census denominator of
175,960 children, we find a prevalence of 0.79%
(0.75%–0.83%). Of these cases, 554 could not be
included in the full protocol of record abstraction
and parental interview. If as many as 20% were non-
ASD cases, the prevalence of already-diagnosed ASD
would be 0.73% (0.69%–0.77%).
Age- and gender-specific estimates appear in Fig-
ure 2. We obtained these estimates by calculating
the distributions from complete records in the QCC,
then applying those same distributions to the sim-
ulated QSS + QCC populations and calculating
group-specific prevalence with denominators from
2015 census data.
For comparison, we also calculated the prevalence
of already-diagnosed ASD derived only from the
school survey. The prevalence of already-diagnosed
ASD from the QSS was 0.83% (0.37%–1.39%). To
arrive at this estimate, we used the same simulation
described above, but substituted the probabilities 3/
760 and 9/163 for already-diagnosed cases among
screen and screen+ children. Summing new and
existing diagnoses, the total prevalence estimated
from the QSS only was 1.15% (0.61%–1.78%). Thus,
both the total prevalence and the prevalence of
already-diagnosed cases were very close using two
independent estimation methods.
Clinical profiles of ASD cases
Clinical data for 844 children (five newly diagnosed
fromQSS,839 fromQCC) are shown inTables 2and3.
The overall male:female ratio was 4.3:1, and the
mean age was 7.24 years. A third of the sample
originated from GCC countries. Children from non-
GCC countries came from Egypt (15.5%), Sudan
(13.0%), India (11.3%), the Philippines (11.0%), Jor-
dan (7.5%), Yemen (7.3%), Syria (4.9%), Pakistan
(3.7%), Lebanon (3.5%), Palestine (3.3%), and the
reminder from 29 other countries. Overall, there were
73.4% of children from Arabic countries and 26.6%
from non-Arabic countries. Of note, the proportion of
Qatari children with ASD (29.5%) was similar to that
(31.8%) of Qatari children in the whole school popu-
lation age 5–12. Consanguinity was reported by 160
(19.9%) parents in the whole sample; however, when
restricted to families from GCC countries, consan-
guinity was endorsed by 116 of 249 families (46.6%)
and by 109 of 233 (46.8%) Qatari families.
The average number of full siblings (not counting
the index child with ASD) was 2.1 (SD = 1.7) and that
of half-siblings was 0.15 (SD = 0.94). After excluding
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Figure 2 Prevalence estimates (95% confidence intervals), by age and gender
Table 2 Socio-demographic and familial characteristics of autism spectrum disorders (ASD) children (N = 844)
All (N = 844) Boys (N = 684) Girls (N = 160) p-Value
Children with ASD
Mean age, mean (SD) 7.24 (1.60) 7.29 (1.62) 7.03 (1.52) .056
Age group, No. (%)
5–6 years 270 (32.0) 210 (30.7) 60 (37.5) .24
7–8 years 375 (44.4) 305 (44.6) 70 (43.8)
9–10 years 142 (16.8) 119 (17.4) 23 (14.4)
11–12 years 57 (6.8) 50 (7.3) 7 (4.4)
Nationality, No. (%)
Qatar 248 (29.5) 206 (30.2) 42 (26.4) .78
Other GCC countries 19 (2.3) 15 (2.2) 4 (2.5)
Other Arabic countries 351 (41.7) 280 (41.0) 71 (44.7)
Other countries 224 (26.6) 182 (26.6) 42 (26.4)
Mother’s age at birth
Mean age, mean (SD) 30.3 (5.43) 30.4 (5.49) 29.8 (5.18) .22
Age group, No. (%)
<20 8 (.9) 6 (1.1) 2 (1.5) .069
20–24 114 (13.5) 88 (15.7) 26 (19.0)
25–29 235 (27.8) 191 (34.0) 44 (32.1)
30–34 295 (23.1) 147 (26.2) 48 (35.0)
35–39 116 (13.7) 102 (18.1) 14 (10.2)
≥40 31 (3.7) 28 (5.0) 3 (2.2)
Father’s age at birth
Mean age, mean (SD) 34.8 (6.48) 35.1 (6.48) 33.8 (6.39) .035
Age group, No. (%)
<20 37 (4.4) 25 (4.4) 12 (8.7) .13
20–24 134 (15.9) 108 (19.1) 26 (18.8)
25–29 223 (26.4) 172 (30.5) 51 (37.0)
30–34 164 (19.4) 136 (24.1) 28 (20.3)
35–39 90 (10.7) 78 (13.8) 12 (8.7)
≥40 54 (6.4) 45 (8.0) 9 (6.5)
Maternal education level, No. (%)
Primary school 30 (3.6) 23 (3.4) 7 (4.6) .54
Secondary school 152 (18.0) 129 (19.1) 23 (15.2)
College 489 (57.9) 394 (58.5) 95 (62.9)
Master or PhD 154 (18.2) 128 (19.0) 26 (17.2)
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children without sibling or with missing data, 42 out
of 659 (6.4%) parents reported to have another child
with ASD either in full (N = 38; 5.8%) or half-siblings
(N = 4; 0.6%), or in a more distant relative in 47
families (7.1%). Combined together, ASD recurrence
among any relative was reported in 11.8% (78/659)
families with available data. Exact sibling recurrence
risks could not be calculated in the absence of
detailed information about sibship size and order.
Similar levels of consanguinity were found in fami-
lies with or without sibling ASD recurrence (26.2%
vs. 22.1%; v2 = .38, df = 1; NS) or any relative ASD
recurrence (27.3% vs. 21.7%; v2 = 1.22, df = 1; NS).
The mean duration of gestation was 39.5 weeks
(SD = 1.47); 5.1% pregnancies had a duration
<37 weeks. Pregnancy was uncomplicated in 700
(86.3%) of 811 cases with information. In the remain-
ing 111 pregnancies, medical complications reported
were diabetes (N = 72; 8.9%), high blood pressure
(N = 26; 3.2%), and other miscellaneous complica-
tions (N = 22; 2.7%). Delivery was by C-section in 239
(29.5%) children; mean birthweight (BW) was 3,149
Table 3 Obstetric, birth, developmental history, and current clinical characteristics of autism spectrum disorders children
(N = 844)
All (N = 844) Boys (N = 684) Girls (N = 160) p-Value
Pregnancy duration in weeks, mean (SD) 39.5 (1.48) 39.6 (1.46) 39.4 (1.52) .23
Prematurity (<37 weeks), No. (%) 41 (5.1) 29 (4.4) 12 (7.7) .095
Obstetric complications
Gestational diabetes, No. (%) 72 (8.9) 56 (8.5) 16 (10.3) .48
Gestational hypertension, No. (%) 26 (3.2) 16 (2.4) 10 (6.5) .011
Any gestational complication, No. (%) 111 (13.7) 84 (12.8) 27 (17.4) .13
Birthweight, mean (SD) 3,149 (565) 3,174 (565) 3,045 (556) .017
Birthweight <2,500 g, No. (%) 56 (8.0) 42 (7.4) 14 (10.4) .24
C-section delivery, No. (%) 239 (29.5) 192 (29.3) 47 (30.5) .76
Postnatal complications
Hypoxia, No. (%) 45 (5.5) 35 (5.3) 10 (6.4) .60
Jaundice, No. (%) 68 (8.4) 58 (8.9) 10 (6.4) .32
Any complication, No. (%) 124 (15.1) 101 (15.3) 23 (14.4) .77
Motor delay
Sitting ≥8 months, No. (%) 60 (7.6) 51 (7.9) 9 (6.0) .42
Walking ≥18 months, No. (%) 66 (8.4) 52 (8.1) 14 (9.5) .57
Language delay
First words ≥24 months, No. (%) 572 (75.1) 461 (74.1) 111 (79.3) .20
First phrases ≥33 months, No. (%) 687 (91.4) 552 (90.9) 135 (93.1) .40
Developmental regression/loss of skills, No. (%) 156 (19.4) 133 (20.3) 23 (15.3) .17
First parental concerns in months, mean (SD) 24.5 (7.7) 24.5 (7.7) 24.5 (7.8) .92
Age at diagnosis in months, mean (SD) 42.8 (15.1) 43.0 (15.3) 42.2 (14.3) .59
Delay between first parental concerns and age at
diagnosis in months, mean (SD)
18.4 (14.1) 18.5 (SD = 14.3) 17.9 (13.1) .67
Current clinical characteristics
Language level
Receptive language
Poor to limited comprehension, No. (%) 594 (71.0) 480 (70.4) 114 (73.5) .43
Expressive language
Limited language, or nonverbal 164 (19.4) 122 (17.8) 42 (26.3) .015
School functioning
Reduced peer interactions, No. (%) 117 (14.0) 89 (13.0) 28 (18.1) .10
Academic performance difficulties, No. (%) 56 (7.0) 45 (6.9) 11 (7.4) .83
Has a learning disability, No. (%) 687 (82.1) 560 (82.1) 127 (81.9) .96
Requires behavioral support at school, No. (%) 172 (20.5) 141 (20.7) 31 (19.9) .82
Behavioral, emotional adjustment
ADHD symptoms, No. (%) 255 (30.2) 213 (31.1) 42 (26.3) .22
Aggression symptoms, No. (%) 47 (5.6) 37 (5.4) 10 (6.3) .68
Anxiety symptoms, No. (%) 93 (11.0) 75 (11.0) 18 (11.3) .92
Behavioral/emotional problem
Any problem, No. (%) 308 (36.5) 256 (37.4) 52 (32.5) .24
Two or more problems, No. (%) 73 (8.6) 57 (8.3) 16 (10.0) .50
Sleeping problems, No. (%) 74 (8.8) 59 (8.6) 15 (9.4) .76
Current interventions
Psychotropic medication, No. (%) 53 (6.5) 41 (6.0) 12 (7.5) .48
Speech/language therapy, No. (%) 35 (4.1) 29 (4.2) 6 (3.8) .78
Behavior therapy, No. (%) 38 (4.5) 32 (4.7) 6 (3.8) .61
Occupational therapy, No. (%) 47 (5.6) 41 (6.0) 6 (3.8) .26
Special Need school, No. (%) 108 (12.8) 86 (12.6) 22 (13.8) .69
Individualized school intervention, No. (%) 102 (12.1) 88 (12.9) 14 (8.8) .15
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grams (SD = 565) with 8% BW under 2,500 g. Com-
plications in the postnatal period were hypoxia
(N = 45; 5.5%), jaundice (N = 68; 8.4%), and other
complications (N = 25; 3.1%); 15 children (1.8%)
experienced two or more complications. Gestational
diabetes increased the odds of gestational hyperten-
sion (11.1% vs. 2.4%; OR = 5.0; 95% CI: 2.1–12.0),
delivery by C-section (41.7% vs. 28.2%; OR = 1.82;
95% CI: 1.11–2.98), prematurity (13.9% vs. 4.2%;
OR = 3.68; 95% CI: 1.72–7.87), low BW (24.6% vs.
6.4%; OR = 4.79; 95% CI: 2.47–9.29), neonatal
hypoxia (19.4% vs. 4.2%; OR = 5.50; 95% CI: 2.77–
10.93) and of any postnatal complication (29.2% vs.
14.0%; OR = 2.54; 95% CI: 1.47–4.40). Mothers with
gestational diabeteswere slightly but not significantly
older (mean age difference: 1.15 years; p = .095) than
mothers without diabetes.
Bothbreastfeeding and formulawere used in 87.9%
of children, with 6.5% on exclusive breastfeeding. A
total of 89 children (11%) required hospitalization
during infancy,most often for seizures (N = 18 (2.2%);
15 (1.85%) for febrile seizures). For19children (2.3%),
parents reported some head trauma with eight chil-
dren (1%) requiring admission. Vaccinations were up
to date in 809 children (96.8%).
Motor milestones were delayed for sitting in 60
children (7.6%) and for walking in 66 children
(8.4%). The median age was 24 months for use of
first words (interquartile range: 23–30 months) and
48 months for phrases (interquartile range: 41–
60 months); 90 children (12.0%) had no phrase
speech at the time of the survey. The frequency of
language delay was 75.1% (572/762) for first words
and 91.4% (687/752) for phrase speech. Parents
reported developmental regression or a loss of skills
in 156 of 806 children (19.4%). The skill most
commonly lost was speech (N = 135; 86.5%) with
17 children (10.9%) having lost at least two skills
(predominantly language and social skills).
The median age for first parental concerns was
24 months (range: 4–60 months), with 77.3% being
concerned by age 24 months (97.4% by age
36 months). The mean age at diagnosis was
42.8 months (median: 36; range: 12–132). About half
the sample (54.0%) was diagnosed by age 36 months,
84.6% by age 48 months and 93.2% by age
60 months. The mean interval between first parental
concerns and age at diagnosis was 18.4 months
(SD = 14.1;median:12 months)andwassignificantly
correlated with both age at diagnosis (Spearman’s
rho = .77; p < .001) and age at first parental concerns
(Spearman’s rho = .25; p < .001).
All children were diagnosed with ASD by multidis-
ciplinary team evaluations with experienced clini-
cians. One standardized diagnostic measure was
used in the majority of cases: the ADOS (Lord et al.,
2002) (N = 600), the ADI-R (Rutter, LeCouteur et al.,
2003; Rutter, Bailey, et al., 2003) (N = 101), and the
CARS (N = 114). Protocols of diagnostic measures
and cognitive tests were often filed separately and
could not generally be abstracted. Of 314 children
with available information, Fragile X disorder was
found in two children (one male, one female), Rett
syndrome in three children (all females), Down
syndrome in two males, Joubert syndrome in one
male, Goldenhar syndrome in one male, blindness in
three males, and hearing impairment in one male.
There was no report of congenital rubella, tuberous
sclerosis, or neurofibromatosis. Epilepsy was
reported by history in 102 children (12.1%; boys:
12.0% and girls: 12.5%; NS).
Current clinical, educational and behavioral char-
acteristics are presented in Table 3. Over two-thirds
of the sample had limitations in receptive language,
whereas a fifth had substantial impairments in
expressive language. The majority of children had
difficulty to learn at school, and about 15%–20% also
appeared socially isolated or required behavioral
support in the classroom. Of the comorbid behav-
ioral problems, ADHD symptoms were the most
common, affecting almost a third of the sample.
Anxiety, ADHD and aggression were strongly asso-
ciated (p < .001) with 36.5% of children showing at
least one emotional or behavioral syndrome, and
8.6% showing at least two of them. Use of psy-
chotropic medications was limited to 53 children
(6.5%) and included risperidone (N = 33), anticon-
vulsants (N = 13) and stimulants or other anti-
ADHD drugs (N = 7). The odds of psychotropic med-
ication use were raised significantly with the pres-
ence of ADHD (11.4% vs. 4.1%; OR = 2.67; 95% CI:
1.48–4.82), marginally with aggression (17.0% vs.
5.7%; OR = 2.26; 95% CI: 0.94–5.40), but not with
anxiety (9.7% vs. 5.9%; OR = 1.11; 95% CI: 0.50–
2.47). Other individual therapies were currently
delivered in a small (5%) proportion of the sample,
whereas school-based interventions were more than
twice as frequent. Other current interventions occur-
ring in fewer than 30 children (not shown in Table 3)
were special diet (N = 18; 2.1%), vitamin supple-
ments (N = 16; 1.9%), and hyperbaric oxygen ther-
apy (N = 6; 0.7%). The frequency of interventions
was much higher when past treatments were
counted, with most children having received speech
and language therapy (96.5%), behavioral interven-
tion (97.0%), and occupational therapy (79.4%).
With the exception of special diet (17.9% of subjects),
other interventions remained at lifetime low levels
(medications: 10.3%; vitamin supplements: 1.9%;
hyperbaric oxygen therapy: 1.1%).
Sex differences
Girls had significantly lower birthweights (Table 3), a
difference that persisted after exclusion of children
of low birthweights (boys: 3,269; girls: 3,173 g;
p = .037). Girls were significantly more impaired
than boys on expressive language functioning and
were more socially isolated from peers although this
was only a trend (Table 3). Otherwise, age at first
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parental concerns and diagnosis, patterns of behav-
ioral/emotional problems, and their comorbidity, as
well as service use, were similar across genders.
ASD severity
Binary logistic regression models evaluated associa-
tions between low versus high severity as measured
by the CSS and 28 independent predictors (see
Table S2). Child gender, paternal and maternal
age, pregnancy duration, prematurity, delivery by
C-section, language delay (first words), age at diag-
nosis, and delay between first parental concerns and
diagnosis were not associated with severity using a
cutoff of p < .15 for variable selection. To prevent
multicollinearity, we dropped birthweight (continu-
ous), any obstetric complication, and any postnatal
complication. The 15 remaining variables (five demo-
graphic/family, five obstetric/perinatal variables,
five developmental/clinical) were entered into a
multivariate logistic regression using the forward
selection procedure. The final model had good fit and
contained four variables: developmental regression
(OR = 2.51; 95% CI: 1.69–3.74) entered the model
first, followed by motor delay (OR = 2.83; 95% CI:
1.59–5.03), gestational diabetes (OR = 2.46; 95% CI:
1.42–4.25), and consanguinity (OR = 1.68; 95% CI:
1.10–2.57). The same final model was obtained using
a backward selection procedure (see full model in
Table S3).
Consanguinity and phenotypic expression
In 249 families (112 consanguineous) from the Gulf
countries, the prevalence of first-degree consanguin-
ity was 45.0% (95% CI: 0.41–0.53%). Consanguinity
was not associated with maternal education, child
gender, or ASD recurrence in siblings and relatives
(all P’s > .50). We further tested for associations
between first-degree consanguinity and 37 clinical
variables included in Table 3. Gestational diabetes
and the occurrence of any obstetric complication
were more frequent in the consanguineous group
(gestational diabetes: 17.9% vs. 8.8%; p = .036; any
gestational complication: 23.6% vs. 11.0%;
p = .009). Compared to children from nonconsan-
guineous parents, children from consanguineous
parents had lower mean birthweights (2,972 vs.
3,235; p = .001) and higher frequency of low BW
(18.2% vs. 2.7%; p < .001). All other 33 comparisons
yielded statistically nonsignificant results.
Discussion
Our study incorporated recent improvements in
autism survey methodology, specifically a general
school population screening to identify undiagnosed
ASD. Participation in the school survey was accept-
able albeit low in the first screening phase. The
screening questionnaire had good specificity only
identifying a small (<10%) manageable proportion of
screen+ children. We succeeded in evaluating a high
number of children in both the screen and screen+
groups permitting precise final case status determi-
nation in almost a thousand participants. Our
reliance on a flexible combination of telephone
interviews and in-person clinical evaluations
enhanced families’ participation while optimizing
our resources. Identification of newly diagnosed
children allowed us to reduce the bias in estimating
prevalence that inevitably occurs when only already-
diagnosed children are ascertained.
Our estimate of 1.14% is broadly in line with
recent studies (Arora et al., 2018; Baio et al., 2018;
Diallo et al., 2018) and reviews (Elsabbagh et al.,
2012; Hill et al., 2014; Meyers et al., 2018). Com-
pared to previous regional surveys (see Table S1),
our more comprehensive methodology resulted in a
much higher estimate. Other factors may have
contributed to the difference; Qatar has a well-
funded medical/educational system allowing access
to services to all its residents, national policies for
individuals with disabilities exist, well-trained teams
with autism expertise were available, public and
professional ASD awareness recently increased, and
funding was readily available.
Our prevalence had two different components. The
school survey component (0.32%) uniquely due to
newly diagnosed children accounted for 28.1%
(0.32/1.14) of the overall prevalence. This compares
to school survey prevalences of 0.50% (57.5% of
overall prevalence) in the Mexico study (Fombonne
et al., 2016) and 1.89% (71.6% of overall prevalence)
in the South Korea study (Kim et al., 2011). These
remarkable disparities may reflect differences in
study methods such as variability in participation
rates and sampling fractions, in screening tools and
diagnostic methods and in weighted statistical anal-
yses. Alternatively, they may reflect true population
differences with respect to autism awareness, detec-
tion and identification of ASD, access to medical
diagnoses, and extent of supportive school services.
However, as the school component proportion
increases steadily with overall prevalence, it is
unlikely that lack of awareness and pervasive under-
diagnosing are contributory since a reverse pattern
would otherwise be expected, with relatively more
undiagnosed cases in lower prevalence studies. Of
note, all studies showed that prevalence would be
underestimated if school surveys had not been per-
formed to identify children without an existing diag-
nosis. The magnitude of the corresponding bias is
difficult to evaluate. In our more conservative study,
the downward bias in prevalence would be 28%.
These findings have implications for designing future
surveys and interpreting existing surveillance data.
Our estimate for 8-year-olds (the age group sur-
veyed by CDC) was 1.53% (Figure 2), which is
similar to the three most recent CDC prevalence of
1.49%, 1.46%, and 1.69% (Baio et al., 2018;
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Christensen et al., 2016; ADDM, 2014). However, it
incorporates a school survey component, a feature
lacking in the CDC methodology. Remarkably, 20%
of cases in CDC surveys were not previously diag-
nosed either. New diagnoses were derived from
record reviews but not confirmed with direct evalu-
ations, resulting in diagnostic validity concerns
(Fombonne, 2018; Mandell & Lecavalier, 2014).
Even when estimates converge, comparisons
between studies should be made cautiously given
numerous method differences that may confound
comparisons in both directions.
A unique study feature was to generate two inde-
pendent estimates for the prevalence of already-
diagnosed cases; one through a head count of
clinical/educational sites, the other derived from a
two-phase survey of the general school population.
Although expected, the convergence of the two esti-
mates (0.83% and 0.82%) was surprisingly close. To
the best of our knowledge, this is the first survey that
provided such an internal replication of its estima-
tion procedures. Future surveys would benefit to
build in their design similar replication approaches.
The performances of the SCQ (Rutter, LeCouteur
et al., 2003; Rutter, Bailey et al., 2003) as a screen-
ing tool proved very adequate. The negative predic-
tive value was very high (757/760 = 99.6%), the
specificity was excellent (757/906 = 83.6%), the
test–retest reliability was satisfactory, and the pos-
itive predictive value (PPV) was acceptable for a
relatively rare disorder (14/163 = 8.6%). Previous
studies reporting similar or better SCQ performance
were usually conducted on clinical samples of
preschoolers, a context very different from our pop-
ulation screening at school age (Charman et al.,
2016). The somewhat low PPV required testing a
relatively high number of children to eliminate false
positives, a common problem in ASD surveys with all
available screening instruments. To achieve higher
specificity and PPV, it may be necessary to employ
multisteps screening approaches rather than to rely
on one-time administration of a questionnaire.
Selecting persistently high scorers over several
administrations of the same or different screening
instruments over short time intervals, or even com-
bining questionnaire-based informant screening fol-
lowed by rapid clinician-driven group procedures to
rule out ASD (Zhou et al., unpublished data) may
improve the efficiency of population screening.
As expected, prevalence was four times as high in
boys than in girls, and there was a trend toward
more severe outcome among girls. Age-specific
prevalence estimates were variable ranging from
0.26 among 11-year-olds to 2.06 among 7-year-olds.
The decline in rates from age 8 to 11 is not consistent
with the natural history of ASD. Because age-specific
estimates were derived solely from the QCC observed
case distribution, the age pattern has no relationship
with the QSS screening results and is unrelated to
the unexpected association of SCQ screening status
and age. Similarly, intriguing results were reported
in a pilot CDC study (Yeargin-Allsopp et al., 2003)
that contributed to choosing age 8 as the most
appropriate age for surveillance. Our age pattern is
consistent with increasing awareness and improved
detection and diagnosis having occurred recently in
Qatar. Likewise, training of ASD teams at our clinical
sites occurred in the late 2000s, and it is therefore
possible that older children, when evaluated as
preschoolers, may have been underdiagnosed and
misclassified. For all these reasons, rates in children
of age 9–11 should be considered as underestimates.
Clinical profiles of ASD in this study were very
similar to those from other population surveys.
There was a typical preponderance of males with
ASD; language delay was a prominent developmental
feature and, consistent with other studies (ADDM,
2014; Zhou et al., unpublished data), regression
often involving language skills occurred in a fifth of
subjects. Also consistent with the literature (Di
Giacomo & Fombonne, 1998; Shattuck et al.,
2009), parents became concerned around 2 years
of age, yet a formal diagnosis was established only
18 months later outlining the long wait experienced
by parents. Nevertheless, an average age at diagno-
sis around 3.5 years compares well with data from
other countries (Shattuck et al., 2009). At the time of
the survey, a substantial proportion of children
showed persisting social and communication defi-
cits, with 12% having no phrase speech. Unfortu-
nately, IQ data were not available on most children,
which was a strong limitation of this study. In line
with other studies (Hartman, Geurts, Franke, Buite-
laar, & Rommelse, 2016; Simonoff et al., 2008),
comorbid behavioral problems were reported in up
to a third of subjects, with ADHD being the leading
associated problems. Use of speech/language, occu-
pational, and behavior therapy were at low levels in
this school-age sample; however, access to these
evidence-based therapies in early childhood was at
much higher rates. It was satisfying that vaccine
uptake was high and use of non-evidence-based
therapies (such as hyperbaric oxygen treatment and
vitamin supplements) remained infrequent.
Our study provided a unique opportunity to exam-
ine consanguinity in a large ASD sample. Consan-
guinity in the sample of Qatar/GCC families was
comparable to other published rates for the Qatari
and GCC populations (e.g. 54% or 46.7%) (Bener &
Alali, 2006; Bener et al., 2013). From these compar-
isons, it does not appear that consanguinity is a risk
factor for ASD although controlled epidemiological
studies would be preferred to test this link. However,
and supporting a lack of relationship between con-
sanguinity and autism risk, we found no relationship
between consanguinity and familial recurrence of
ASD. By contrast, consanguinity predicted ASD
severity after controlling for the effect of maternal
health and developmental indicators. This original
finding suggests that background genetic factors and
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increased homozygosity may modulate ASD pheno-
typic expression beyond and above the effect of
primary causal, genetic or otherwise, risk factors.
This novel finding requires replication, but it is worth
noting that increased disease severity in offspring of
consanguineous parents has already been reported,
for example for congenital heart defects associated
with Down syndrome (Bittles & Black, 2010).
Evidence from other studies or meta-analyses sug-
gests that gestational diabetes, gestational hyperten-
sion, C-section, low BW, and hypoxia are risk factors
for ASD (Curran et al., 2018; Flygare Wallen, Ljung-
gren, Carlsson, Pettersson, & W€andell, 2018; Hisle-
Gorman et al., 2018; Maher et al., 2018; Xu, Jing,
Bowers, Liu,&Bao,2014).Compared toQatar studies
(Bener, Saleh, &Al-Hamaq, 2011; Bener et al., 2013),
our observed rates were not raised; however, in the
absence of non-ASD controls, interpretation must be
guarded. Our data suggested that gestational dia-
beteswas a significant predictor of other obstetric and
perinatal complications, as shown in other studies in
Qatar (Bener et al., 2011) and elsewhere. Interest-
ingly, gestational diabetes was the only obstetric and
perinatal variable that remained a significant predic-
tor of severity in our multivariate analysis; five other
variables (prematurity, hypertension, low birth-
weight, hypoxia, and jaundice) that predicted severity
in unadjusted binary models lost significance when
gestational diabetes was adjusted for. Unfortunately,
further analyses of gestational diabetes were limited
aswedidnothavedata onpotential confounders such
as maternal obesity, prepregnancy body mass index,
gestational weight gain, as well as interpregnancy
interval and parity.
Besides gestational diabetes and consanguinity,
severitywas independently associatedwith twodevel-
opmental clinical features. First, delay inwalkingwas
reported at a relatively high frequency in our sample
and likely acted as aproxy variable for cognitive delay.
Second,developmental regression independentlypre-
dicted severity once the effect of other predictors was
adjusted for, a finding consistentwithmost published
studies (Bernabei, Cerquiglini, Cortesi, & D’Ardia,
2007; Meilleur & Fombonne, 2009; Richler et al.,
2006; Zachor & Ben-Itzchak, 2016). Loss of skills
was reported in about a fifth of children with ASD, a
proportion which is consistent with that reported in
previous clinical (Meilleur & Fombonne, 2009) and
epidemiological samples (Thurm, Powell, Neul, Wag-
ner,&Zwaigenbaum,2018).Sinceregression ishighly
specific to ASD (Pickles et al., 2009), occurs in the
second year of life, and predicts later severity,
improvedrecognitionof thisearlymarkerofASDcould
help direct early intervention to vulnerable children
and ameliorate ASD developmental trajectories.
Our investigation has several strengths including
comprehensive case identification at the population
level, the addition of a general school survey to
identify undiagnosed children, reliance on both
health and education sources to ascertain cases,
use of autism-specific screening instruments and
diagnostic tools, a large sample size, a high propor-
tion of screened children assessed for caseness
determination (especially that achieved for screen-
negative participants), statistical analyses that
increased confidence in the estimates, and novel
findings on consanguinity. Some limitations are also
noted. First, like in other school surveys (Fombonne
et al., 2016; Kim et al., 2011), parent participation
was low and no data were available to evaluate
whether or not participation was differentially asso-
ciated with caseness. As a result, we hypothesized,
but could not demonstrate, that nonparticipation
was independent of the presence/absence of ASD in
the family. As a consequence, the school survey
prevalence component could have been overesti-
mated. Second, our plan to abstract clinical infor-
mation on all prevalent cases could not be fully
executed due to limited resources. Yet, there was
evidence that abstracted and unabstracted cases
were comparable and sensitivity analyses showed
limited impact of potential misclassification on
prevalence estimates. Third, data available from
record reviews supplemented by parental reports
did not include scores of standardized tests, both
diagnostic and cognitive, or results of medical tests.
There are several take-home messages. First, our
results support adding population screening to
increase sensitivity of case ascertainment in epi-
demiological studies. Second, considering our 1.14%
prevalence and GCC population demographics, we
estimated that, in GCC countries, there are about
50,500 children under age 5 and 137,000 subjects
in the 5–19 age range with ASD (Qatar only: 1,575
and 5,025, respectively). These figures point at the
need both for early detection, diagnosis and early
intervention programs for preschoolers and for edu-
cation, intervention and vocational training pro-
grams required at later ages, in order to reduce
individual and societal costs associated to autism
across the life span (Buescher, Cidav, Knapp, &
Mandell, 2014). Third, we validated tools and a
survey methodology for Qatar that can be effectively
deployed in other countries in the region. Fourth, the
results of this first survey should be regarded as a
baseline against which future monitoring of ASD
incidence and prevalence in Qatar can be calibrated.
Finally, children of our prevalence pool and their
families have been already invited to participate in a
national registry that will facilitate future research
on individuals with ASD of all ages.
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Key points
• Qatar first ASD prevalence estimate of 1.14% is consistent with that of other populations.
• The methodology of this survey confirms that comprehensive case ascertainment requires systematic screening
of the general child population in order to identify yet-undiagnosed children with ASD.
• Compared to the general population, consanguinity between parents of children with ASD was not raised, and
recurrence of ASD within families was not associated with consanguinity. However, consanguinity predicted
increased severity of ASD.
• We estimated that 187,000 youths under age 20 have ASD in Arabic countries within the Gulf region; these
figures have implications for planning improved health and education services.
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